Since 2021, Intel’s quarterly revenues have contracted by approximately one-third as the company struggles to retain clients migrating to alternative architectures. The high-profile departure of a major notebook customer accounted for over 15% of total revenue, exacerbating an already downward-sloping sales trajectory. Despite receiving an $8.9 billion infusion from federal incentives to expand domestic production, Intel reported a negative operating margin in its latest fiscal quarter. Manufacturing delays on next-generation process nodes have pushed expected output timelines back by six to nine months, contributing to escalating unit costs and inventory write-downs exceeding $1 billion year to date.

Analysts recently upgraded Intel from Hold to Buy, assigning a long-term valuation target that implies roughly 25% upside from current consensus levels. This outlook rests on anticipated yield improvements on the firm’s 18-angstrom node, which are projected to boost gross margin by 3 to 4 percentage points by late next year. Strategic collaboration talks with leading AI customers—including potential foundry agreements with a top GPU designer and a cloud services provider—could unlock additional wafer volumes. If Intel can achieve its roadmap of high-volume manufacturing in the fourth quarter and ramp production to planned capacity, operating leverage from those partnerships may help stabilize earnings before interest and taxes within 12 to 18 months.